Galapagos NV
GLPG
#4563
Rank
ยฃ1.58 B
Marketcap
ยฃ23.70
Share price
-0.57%
Change (1 day)
11.93%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ2.15 Billion

According to Galapagos NV's latest financial reports the company has ยฃ2.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ2.40 B-0.97%
2023-12-31$ยฃ2.42 B8.31%
2022-12-31$ยฃ2.23 B0.99%
2021-12-31$ยฃ2.21 B-7.96%
2020-12-31$ยฃ2.40 B-1.91%
2019-12-31$ยฃ2.45 B124.49%
2018-12-31$ยฃ1.09 B21.8%
2017-12-31$ยฃ0.89 B38.91%
2016-12-31$ยฃ0.64 B140.16%
2015-12-31$ยฃ0.26 B67.24%
2014-12-31$ยฃ0.16 B15.08%
2013-12-31$ยฃ0.13 B44.35%
2012-12-31$ยฃ96.93 M-1.99%
2011-12-31$ยฃ98.9 M-22.71%
2010-12-31$ยฃ0.12 B32.74%
2009-12-31$ยฃ96.39 M19.85%
2008-12-31$ยฃ80.43 M10.96%
2007-12-31$ยฃ72.48 M-1.77%
2006-12-31$ยฃ73.79 M75.71%
2005-12-31$ยฃ41.99 M473.32%
2004-12-31$ยฃ7.32 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
ยฃ34.48 B 1,500.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ59.46 B 2,660.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ64.72 B 2,905.07%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-ยฃ1.95 Billion-190.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
ยฃ28.04 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ38.45 B 1,685.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ5.44 B 152.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ15.88 B 637.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ38.93 B 1,707.52%๐Ÿ‡บ๐Ÿ‡ธ USA